3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market

The article highlights AbbVie, Chevron, and Vici Properties as high-yield dividend stocks with strong fundamentals and defensive characteristics. AbbVie yields 3.3% versus the S&P 500’s 1.2%, Chevron yields 3.8% after a 23% YTD gain, and Vici Properties yields 6.3% with 2022 total returns around 13%. The piece is primarily a bullish stock-picking commentary rather than new company-specific news, so near-term market impact should be limited.

Analysis

This is less a pure “dividend” story than a late-cycle quality bid with three different duration profiles: ABBV is a cash-flow compounder with idiosyncratic patent/launch risk, CVX is a macro hedge on persistent energy tightness, and VICI is a rate-sensitive bond proxy with operating leverage to consumer resilience. In a risk-off tape, capital tends to rotate toward names where the dividend is not just large, but visibly covered by near-term free cash flow; that makes these stocks attractive relative to lower-quality yielders where payout risk rises first.

The second-order effect is that the crowding trade is likely in defensive income, not in these specific names. If rates drift lower, VICI’s equity duration can re-rate fastest, while ABBV should benefit from a multiple re-anchoring as investors pay up for visible cash returns plus pipeline optionality. CVX is the most macro-dependent: if crude stays elevated, the market will tolerate a lower current yield because buybacks and dividend growth become the real total-return engine; if oil mean-reverts, the stock can still work, but the multiple compression risk is larger than for the other two.

Consensus is probably underestimating how much these names can outperform in a down market without requiring heroic growth assumptions. The key contrarian point is that the market often overpays for “growth optionality” and underpays for balance-sheet-backed cash distribution until volatility spikes; these are the kind of stocks that get bid when investors stop trusting duration. The main reversal catalysts are not company-specific but regime shifts: a sharp equity melt-up reduces the relative appeal of yield, while a sustained spike in rates would pressure VICI first and a collapse in oil would test CVX’s defensive halo.

Key Decisions for Investors

• Go long ABBV on any 3-5% pullback and target a 3-6 month re-rating toward premium defensives; risk/reward is attractive if the market continues to prize covered yield plus pipeline visibility.
• Use CVX as a tactical hedge against geopolitical/oil upside: initiate a core long but pair it against a more rate- and growth-sensitive long if energy weakens; upside is strongest over 1-2 quarters when crude remains firm.
• Buy VICI on rate-led weakness and consider a 6-12 month call spread to express lower-rate downside protection; biggest risk is a renewed move higher in Treasury yields.
• Pair trade: long ABBV / short a lower-quality high-yield healthcare or REIT basket to isolate payout durability; this works best if credit spreads widen and investors discriminate on coverage.
• For income-focused risk, prefer these covered cash generators over chasing higher nominal yield; the better reward comes from avoiding dividend cuts, not maximizing current payout.